NIH-funded research R21 grant

Shockwave therapy to help reduce spasticity after spinal cord injury

Official title: Randomized, sham-controlled trial to investigate extracorporeal shockwave therapy as an adjunctive treatment for spasticity secondary to spinal cord injury

Funded at Kessler Foundation, INC. · NIH-11438642 · Data updated 2026-11-12

A randomized, sham-controlled trial will test whether extracorporeal shockwave therapy can lessen muscle tightness in people with spinal cord injuries.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionKessler Foundation, INC.
NIH-funded
Lab location1 site (East Hanover, UNITED STATES)
Project startSeptember 1, 2026
Project endJune 30, 2028
Funding year2026
Award (this year)$385,776
NIH project number1R21HD123083-01
Project IDNIH-11438642 on NIH RePORTER

Who could benefit from this research

Could help

Adults with spinal cord injury experiencing spasticity who have not contraindicated conditions and can participate in a randomized trial.

Less likely to help

Individuals without spasticity or with contraindications to shockwave therapy may not benefit.

What this research studies

This trial will compare real shockwave therapy to a sham treatment to see if spasticity improves in people with SCI. It will recruit participants and deliver treatments in a controlled, blinded setup to measure changes in muscle stiffness and function. If effective, this adjunctive therapy could offer a new option alongside existing treatments like botulinum toxin. The study focuses on SCI-related spasticity and will monitor safety and tolerability closely.

Why it matters

Potential benefit: If successful, participants may experience reduced spasticity and improved ability to move and perform daily activities.

How similar studies have gone: Prior studies in stroke patients showed benefit, but similar work in SCI is needed and this trial aims to establish that.

Where this research is happening

  • Kessler Foundation, INC.
    East Hanover, United States
    Active

Researchers

  • Principal investigator: Hogaboom, Nathan — Kessler Foundation, INC.
  • Study coordinator: Hogaboom, Nathan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.